Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. Alterola Biotech, Inc. was founded in 2021 and is based in Birkenhead, the United Kingdom.
Stock data | 2024 | Change |
---|---|---|
Price | $0.003 | N/A |
Market Cap | $4.10M | N/A |
Shares Outstanding | 1.37B | N/A |
Employees | 0 | N/A |